February 17, 1988 |
San Diego Securities and two other securities firms failed to properly execute buy and sell orders during the avalanche of stock trades that followed the Oct. 19 market crash, according to a federal lawsuit filed Monday by an insurance company. The suit demands more than $660,000 in actual damages in addition to unspecified damages. Also named are Thomas Green & Associates, a Los Angeles-based securities firm, and Broadcort Capital Corp., a Merrill Lynch, Pierce, Fenner & Smith Inc.
April 18, 1989
Stocks were awaiting the release of the Consumer Price Index expected out today) before making a run at a new recovery high, said Irving Katz, director of research for Thomas Greene/San Diego Securities. The largest percentage gainer of the week was Molecular Biosystems, gaining $3.75 to make a new high of $23. No announcement has been made since its $31-million marketing pact with a Japanese pharmaceutical firm to market its Albunex ultrasound contrast agent. Price Co. gained $3.25 as reservations about the imminent preferred share dividend became secondary to the prospects of Price's excellent growth potential.
June 27, 1989
With the Dow Jones Industrial Average up nearly 50 points Friday and down 20 points Monday, the only message to investors was uncertainty, said Irving Katz, director of research at Thomas Green/San Diego Securities. Two San Diego-based stocks, however, fell out of favor with analysts and their institutional investor clients and suffered dramatic drops. Advanced Marketing Services fell $5.75, or 34%, for the week as it announced that it expects to report substantially lower earnings in its first fiscal quarter.